Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Pharmaceutical Research|August 11, 2001
Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarinJ W Miller, A Skerjanec, M P Knadler, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Absorption studies of the H2-blocker nizatidineM P Knadler, R F Bergstrom, J T Callaghan, et al.
Journal of Pharmaceutical Sciences|January 1, 1985
Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humansA Rubin, M P Knadler, P P Ho, et al.
Clinical Endocrinology|February 15, 2000
Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbitsN H Bjarnason, J Haarbo, I Byrjalsen, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 25, 2005
Duloxetine pharmacokinetics in cirrhotics compared with healthy subjectsA Suri, S Reddy, C Gonzales, et al.
Clinical Pharmacology and Therapeutics|June 1, 1990
Secretion of nizatidine into human breast milk after single and multiple dosesB D Obermeyer, R F Bergstrom, J T Callaghan, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Modulation of enantioselective metabolism and inversion of ibuprofen by xenobiotics in isolated rat hepatocytesQ Xiaotao, S D Hall
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Enantioselective effects of experimental diabetes mellitus on the metabolism of ibuprofenX Oian, S D Hall
Chemico-Biological Interactions|March 1, 1994
The role of coenzyme A in the biotransformation of 2-arylpropionic acidsS D Hall, X Quan
Pageof 11